10 projets européens trouvés
Recherche sur 125080 projets européens
TERMINÉ
Combatting Bacterial Resistance in Europe - Carbapenem Resistance (COMBACTE-CARE)
Date du début: 1 mars 2015, Date de fin: 28 févr. 2020,
Multi-drug resistant Gram-negative bacteria (MDR-GNB): the ultimate challenge!Antibiotic resistance is a global public health concern recently elevated to the top three threats identified by the WHO, and subject of numerous national and international government activities. Although focused strategies have beneficially influenced infection rates due to methicillin resistant Staphylococcus aureus (M ...
Voir le projet
23
Participants partenaires
TERMINÉ
Novel marine biomolecules against biofilm. Application to medical devices. (NOMORFILM)
Date du début: 1 avr. 2015, Date de fin: 31 mars 2019,
Microalgae are a source of secondary metabolites useful as new bioactive compounds. Activity of these compounds against bacterial pathogens and biofilm formation has not been determined yet. Biofilm formation is especially important in infections and tissue inflammation related to implants and catheters. These problems finally cause a release of the implant, which must be removed and replaced by a ...
Voir le projet
15
Participants partenaires
TERMINÉ
Control of leishmaniasis, from bench to bedside and community (EUROLEISH-NET)
Date du début: 1 janv. 2015, Date de fin: 31 déc. 2018,
Leishmaniasis control is the topic for EUROLEISH-NET, a Marie Sklodowska-Curie – Innovative Training Network. Leishmaniasis is a neglected infectious disease and a major public health and veterinary problem that afflicts both developing countries and Europe. The current technological and epidemiological advances underpin the necessity to develop training programmes aiming at developing new tools a ...
Voir le projet
9
Participants partenaires
TERMINÉ
Molecular basis of the outer membrane permeability (TRANSLOCATION)
Date du début: 1 janv. 2013, Date de fin: 31 déc. 2017,
Overcoming the barriers that the cell envelope and efflux pumps provide to Gram-negative bacteria is a major bottleneck in the discovery and development of new antibiotics. To respond to this Call we are extending our current network on antibiotic translocation and propose an ambitious project ranging from identification of novel resistance mechanisms in clinical bacterial isolates to crystallizat ...
Voir le projet
28
Participants partenaires
TERMINÉ
"Clinical and public health research to improve maternal, newborn health and to control sexually transmitted infections" (MNSIRSES)
Date du début: 1 janv. 2014, Date de fin: 31 déc. 2017,
"The overall aim of the proposed staff exchange programme is to establish a long lasting collaboration between Moroccan, South African and European research teams involved in clinical epidemiological and public health research. This effort should ultimately lead to improved mother and child health and better control of sexual transmitted diseases. The proposal is therefore structured in seven work ...
Voir le projet
7
Participants partenaires
TERMINÉ
Parasite glycobiology and anti-parasitic strategies (GLYCOPAR)
Date du début: 1 déc. 2013, Date de fin: 30 nov. 2017,
"Protozoan parasites and helminths are the cause of some of the most devastating diseases worldwide and a major effort is needed to be able to control or eliminate these diseases. Glycoconjugates are abundant and ubiquitous on the surface of many parasites and they are frequently involved in their survival strategies by forming a protective barrier against host defences. A common feature of the pa ...
Voir le projet
13
Participants partenaires
TERMINÉ
HIV-malaria co-infections: a significant source of antimalarial drug resistance? (HIVMALARIA)
Date du début: 1 juil. 2014, Date de fin: 30 juin 2016,
The rise and spread of drug resistant malaria parasites is one of the major challenges for malaria control and may soon proof to be one of the biggest obstacles to malaria eradication. Due to extensive geographical overlap of HIV and malaria, the two most serious health problems in the world, co-infections are common in nature. These co-infections may increase the emergence and spread of malaria d ...
Voir le projet
2
Participants partenaires
TERMINÉ
Towards the establishment of a permanent European Virtual Institute dedicated to Malaria Research (EVIMalaR) (EVIMalaR)
Date du début: 1 oct. 2009, Date de fin: 31 mars 2015,
This is a proposal from 55 partners from 36 institutes to form a NoE that will seek to integrate European malaria research that is directed towards a better understanding of the basic biology of the parasite, its vector and of the biology of the interactions between the parasite and both its mammalian host and vectors. All the member institutes and researchers have demonstrated both their excellen ...
Voir le projet
40
Participants partenaires
TERMINÉ
Identifying correlates of protection to accelerate vaccine trials: systems evaluation of two models of experimentally-induced immunity to malaria (SysMalVac)
Date du début: 1 janv. 2013, Date de fin: 31 déc. 2014,
Vaccine development is an empirical process (trial and error) and involves a long, expensive clinical development pipeline to license an efficacious vaccine candidate. Better tools for vaccine evaluation are needed to adapt to a rising number of candidate vaccines entering clinical trials for many diseases. Surrogate biomarkers of immunity offer the possibility of expediting the clinical developme ...
Voir le projet
8
Participants partenaires
TERMINÉ
Initiative on Optimizing Malaria Vaccine Lab Assays Evaluation (OPTIMALVAC)
Date du début: 1 avr. 2009, Date de fin: 31 mars 2012,
"A broad-range of candidate malaria vaccines derived from diverse novel technologies have resulted from the multiple approaches being taken by different groups in developing malaria vaccines. The majority of the candidates are recombinant proteins based on complex native antigens found on the surface of the parasite. Vaccine potential of these parasite surface antigens is often supported by epidem ...
Voir le projet